Description
Retatrutide 40mg is a high-purity research peptide studied for its interaction with metabolic hormone signalling pathways. This synthetic peptide has gained significant attention within the scientific community due to its unique triple-receptor agonist activity, targeting GLP-1, GIP, and glucagon receptors simultaneously.
Retatrutide differs from earlier peptide compounds by targeting multiple metabolic signalling systems instead of focusing on a single receptor pathway. Researchers are investigating how this combined receptor activity may impact energy balance, metabolic regulation, and hormone signalling in controlled laboratory settings.
Mechanism of Action (Research Context)
Retatrutide is classified as a triple hormone receptor agonist, meaning it interacts with three key receptor systems involved in metabolic signalling:
- GLP-1 (Glucagon-like peptide-1) – studied for its role in glucose regulation and appetite signalling
- GIP (Glucose-dependent insulinotropic polypeptide) – examined for its influence on insulin response and nutrient metabolism
- Glucagon receptors – investigated for their involvement in energy expenditure and metabolic pathways
By activating these receptors simultaneously, Retatrutide provides researchers with a valuable compound for exploring multi-pathway metabolic signalling and endocrine system interactions.
Research Interest
In preclinical and clinical investigations, compounds targeting these hormone pathways have attracted attention in fields such as:
- Metabolic and endocrine research
- Obesity and weight-regulation studies
- Glucose and insulin signalling investigations
- Energy metabolism research
Because of its multi-receptor activity, Retatrutide represents a new generation of incretin-based peptide research compounds, enabling scientists to examine how coordinated hormone signalling affects metabolic outcomes.
Product Details
- Compound: Retatrutide
- Amount: 40mg
- Form: Lyophilised peptide powder
- Purity: High-purity research grade
- Application: Laboratory and scientific research only
Important Notice
Retatrutide is an investigational compound currently undergoing clinical trials and has not been approved for medical use by regulatory authorities.
This product is intended strictly for laboratory research and analytical purposes only. It is not for human or veterinary consumption.
